Geminus Therapeutics Overview
- Founded
- 2020
- Status
- Private
- Latest Deal Type
- Early Stage VC
- Latest Deal Amount
- $150K
- Investors
- 1
Geminus Therapeutics General Information
Description
Developer of Artemisinin for treating leukemia in Baltimore, Maryland. The company is currently operating in stealth mode.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Primary Office
- 8 Market Place
- Suite 300
- Baltimore, MD 21202
- United States
Geminus Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 22-Nov-2021 | $150K | 00000 | Completed | Stealth |
Geminus Therapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| TEDCO | Venture Capital | Minority | 000 0000 | 000000 0 |